Are You a Healthcare Professional?

This website is intended to provide information about the PAXIS clinical trial for patients with VEXAS Syndrome.

Yes No

The PAXIS clinical trial is a randomized, double-blind, placebo-controlled phase 2 study of pacritinib in patients with VEXAS Syndrome.